Join to View Full Profile
101 The City DrOrange, CA 92868
Phone+1 714-456-8000
Fax+1 855-211-3729
Dr. Mehta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 1992 - 1995
Westchester Medical CenterResidency, Internal Medicine, 1989 - 1992
M.G.M. Medical CollegeClass of 1982
Certifications & Licensure
CA State Medical License Active through 2026
Board CertificationBoard Certified in Oncology
Awards, Honors, & Recognition
- castle connolly
- Top Doctor Castle Connolly, 2014-2019
- Exceptional Women in Medicine Castle Connolly, 2017-2018
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsDisparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, ...Chimezie D Ubbaonu, Jenny Chang, Argyrios Ziogas, Rita S Mehta, Kari J Kansal
Cancers. 2023-11-26 - Effects ofandgenotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, Christina L Gersch, Ted A Vandenberg
Pharmacogenomics. 2023-08-01 - 2 citationsThymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).Mattias Bergqvist, Adrian Nordmark, Amy Williams, Costanza Paoletti, William Barlow
Biomarkers. 2023-05-01
Press Mentions
San Antonio Breast Cancer Symposium: More to Come on 2011 Practice ChangersNovember 28th, 2012
Committees
- Member, SWOG Breast translational Committee 2017 - Present
- Member, Breast committee and Member, Breast working group, SWOG 2001 - Present
- Member, CTPRMC 2009 - 2019
Professional Memberships
- Member
Industry Relationships
- Advisory Board, NovartisAdvisory boardDisclosure: Novartis2019 - 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
